We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
-27.56%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$1.77B
AUM Growth
-$1.21B
Cap. Flow
-$10.5M
Cap. Flow %
-0.6%
Top 10 Hldgs %
12.3%
Holding
1,254
New
453
Increased
136
Reduced
157
Closed
433

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28.3M
2
TW icon
Tradeweb Markets
TW
+$11.9M
3
QURE icon
uniQure
QURE
+$10.5M
4
ON icon
ON Semiconductor
ON
+$7.63M
5
INST
Instructure, Inc.
INST
+$7.04M

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.14%
2 Healthcare 5.46%
3 Consumer Discretionary 4.39%
4 Technology 1.81%
5 Industrials 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPLX icon
651
MPLX
MPLX
$60B
$283K 0.02%
+24,300
New +$498K
ET icon
652
Energy Transfer Partners
ET
$73B
$281K 0.02%
61,200
+13,200
+28% +$141K
PARA
653
PUT
DELISTED
Paramount Global Class B
PARA
$280K 0.02%
20,000
-50,000
-71% -$1.43M
SHW icon
654
Sherwin-Williams
SHW
$77.7B
$275K 0.02%
1,800
AMJ
655
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$274K 0.02%
+30,400
New +$531K
EVH icon
656
CALL
Evolent Health
EVH
$419M
$272K 0.02%
+50,000
New +$447K
UEIC icon
657
Universal Electronics
UEIC
$69.3M
$272K 0.02%
+7,100
New +$322K
RH icon
658
CALL
RH
RH
$2.4B
$271K 0.02%
+2,700
New +$503K
RH icon
659
PUT
RH
RH
$2.4B
$271K 0.02%
+2,700
New +$503K
ADNT icon
660
Adient
ADNT
$1.36B
$265K 0.02%
29,400
+16,500
+128% +$332K
LUMN icon
661
CALL
Lumen
LUMN
$6.69B
$265K 0.02%
28,000
MTDR icon
662
CALL
Matador Resources
MTDR
$7.05B
$264K 0.01%
+106,400
New +$1.17M
NERV icon
663
CALL
Minerva Neurosciences
NERV
$164M
$261K 0.01%
+5,438
New +$328K
LPX icon
664
Louisiana-Pacific
LPX
$4.57B
$257K 0.01%
+15,000
New +$415K
SGMO
665
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$255K 0.01%
40,000
-10,000
-20% -$74.2K
SGMO
666
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$255K 0.01%
40,000
+25,000
+167% +$186K
OCUL icon
667
CALL
Ocular Therapeutix
OCUL
$2.21B
$248K 0.01%
+50,000
New +$247K
ADVM
668
CALL
DELISTED
Adverum Biotechnologies
ADVM
$245K 0.01%
2,500
S
669
DELISTED
Sprint Corporation
S
$243K 0.01%
28,200
-189,900
-87% -$1.33M
DAC icon
670
CALL
Danaos Corp
DAC
$2.95B
$240K 0.01%
+60,000
New +$367K
INSM icon
671
Insmed
INSM
$26.3B
$240K 0.01%
15,000
-70,000
-82% -$1.66M
STAA icon
672
STAAR Surgical
STAA
$1.04B
$240K 0.01%
+7,461
New +$251K
CORT icon
673
Corcept Therapeutics
CORT
$12.3B
$237K 0.01%
20,000
-3,900
-16% -$48.3K
PI icon
674
Impinj
PI
$5.57B
$237K 0.01%
14,200
CMA
675
DELISTED
Comerica
CMA
$235K 0.01%
+8,000
New +$434K

Similar funds

Caption Management's Q1 2020 Portfolio in Review

As of Q1 2020, Caption Management held 1,254 positions worth $1.77B, down 41% from $2.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Caption Management's Q1 2020 filing shows 453 new, 136 increased, 157 reduced and 433 closed positions. Its largest new stake was Wayfair: 142,544 shares worth $7.62M. The largest sale was Medicines Co, an estimated $28.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 84% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Caption Management's largest Q1 2020 buy was Wayfair: 142,544 shares worth $7.62M.
  • Caption Management added most to GE Aerospace in Q1 2020, an estimated $8.43M increase.
  • Caption Management's biggest Q1 2020 reduction was uniQure, cutting an estimated $10.5M.
  • Caption Management fully exited Medicines Co in Q1 2020, selling an estimated $28.3M.
  • Caption Management's ten largest holdings make up 12% of its $1.77B portfolio in Q1 2020.
  • Caption Management opened 453 new positions and closed 433 in Q1 2020.
  • Caption Management's portfolio value fell 41% quarter-over-quarter to $1.77B.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.